EEF2-inactivating toxins engage the NLRP1 inflammasome and promote epithelial barrier disruption Yazar: Pinilla, Miriam, Mazars, Raoul, Vergé, Romain, Gorse, Leana, Paradis, Margaux, Suire, Bastien, Santoni, Karin, Robinson, Kim Samirah, Toh, Gee Ann, Prouvensier, Laure, Leon-Icaza, Stephen Adonai, Hessel, Audrey, Péricat, David, Murris, Marlène, Guet-Revillet, Hélène, Henras, Anthony, Buyck, Julien, Ravet, Emmanuel, Zhong, Franklin, Cougoule, Céline, Planès, Rémi, Meunier, Etienne

Konular: Tam Metin Erişim

Elongation factor 2 in cancer: a promising therapeutic target in protein translation Yazar: Xuechao Jia, Chuntian Huang, Fangfang Liu, Zigang Dong, Kangdong Liu

Konular: “…Elongation factor 2…”
Tam Metin Erişim

2,4-disubstituted 6-fluoroquinolines as potent antiplasmodial agents: QSAR, homology modeling, molecular docking and ADMET studies Yazar: Gideon A. Shallangwa, PhD, Aliyu W. Mahmud, MSc, Adamu Uzairu, PhD, Muhmmad T. Ibrahim, PhD

Konular: Tam Metin Erişim

Silencing eEF2K combined with sodium tanshinone ⅡA sulfonate synergistically inhibit proliferation of human lung adenocarcinoma cell line A549 Yazar: WANG Bu, YUAN Sheng-fang, ZHANG Chang-hong, YUAN Cheng, HUANG Pan-deng, ZHANG Zhi-hua, ZHAO Jian-qing

Konular: “…lung adenocarcinoma|eukaryotic elongation factor 2 kinase|sodium tanshinone ⅱa sulfonate|proliferation|invasion…”
Tam Metin Erişim